Antihypertensive Efficacy and Tolerability and Determine the Adequate Antihypertensive Dosage of Fimasartan in Mild to Moderate Essential Hypertension Patients
Clinical trial NCT00923611 · COMPLETED
Trial details
- NCT number
- NCT00923611
- Sponsor
- Boryung Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2008-06-01
- Enrollment
- 182
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.